Basic aspects of estrogen action

Breast Cancer Research

Volumn 2, Issue 5, 2000, Pages 360-366

  Nilsson, Stefan ^a   Gustafsson, Jan Åke ^b  

^a Karo Bio   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast; Central nervous system; Estrogen receptor ; Estrogen receptor knockout mice; Heterodimerization; Prostate; Uterus

Indexed keywords

ADENOHYPOPHYSIS HORMONE; ANTIESTROGEN; AROMATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FOLLITROPIN; GROWTH HORMONE; HYPOPHYSIS HORMONE; ISOPROTEIN; LUTEINIZING HORMONE; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; PROLACTIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; ESTROGEN RECEPTOR;

ANIMAL TISSUE; ATHEROSCLEROSIS; BONE ATROPHY; BONE DEVELOPMENT; BREAST; BREAST CANCER; BREAST DEVELOPMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DEPRESSION; ESTROGEN THERAPY; FEMALE; GROWTH RETARDATION; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MOUSE; NONHUMAN; OSTEOPOROSIS; PROSTATE CANCER; RAT; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TISSUE DISTRIBUTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; TREATMENT FAILURE; URGE INCONTINENCE; UROGENITAL SYSTEM; ANIMAL; GENETIC TRANSCRIPTION; PHYSIOLOGY; TRANSCRIPTION INITIATION;

ANIMALS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HUMANS; RECEPTORS, ESTROGEN; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 0034466973     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr81     Document Type: Review

References (113)

1. Basic guides to the mechanism of estrogen action
2. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A
3. Sequence and expression of human estrogen receptor complementary DNA
4. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
5. ERβ: Identification and characterization of a novel human estrogen receptor
6. Human estrogen receptor β - Gene structure, chromosomal localisation and expression pattern
7. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β
8. Identification of estrogen receptor β2, a functional variant of estrogen receptor β expressed in normal rat tissues
9. Functional analysis of a novel estrogen receptor-β isoform
10. Molecular cloning and characterization of human estrogen receptor βcx: A potential inhibitor of estrogen action in human
11. Estrogen receptor mutations in breast cancer
12. Estrogen regulates the expression of several different estrogen receptor mRNA isoforms in rat pituitary
13. Multiple splicing variants of the estrogen receptor are present in individual human breast tumors
14. Specific modulation of estrogen receptor mRNA isoforms in rat pituitary throughout the estrous cycle and in response to steroid hormones
15. Estrogen receptor variants and mutations
16. Estrogen receptor mutations
17. The steroid and thyroid hormone superfamily
18. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
19. Transcription factors 3: Nuclear receptors
20. The nuclear receptor superfamily: The second decade
21. Nuclear hormone receptors: Ligand-activated regulators of transcription and diverse cell responses
22. Orphan nuclear receptors: From gene to function
23. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain
24. Analysis of estrogen receptor function in vitro reveals three distinct classes of anti-estrogens
25. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
26. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action
27. The human estrogen receptor has two independent nonacidic activation functions
28. Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen
29. Ligand-dependent transcriptionally productive association of the amino- and carboxy-terminal regions of a steroid hormone nuclear receptor
30. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation
31. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists
32. Transcription activation by the human estrogen receptor subtype β (ERβ) studied with ERβ and ERα receptor chimeras
33. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
34. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors
35. Structure and specificity of nuclear receptor-coactivator interactions
36. Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors
37. Molecular determinants of the estrogen receptor-coactivator interface
38. Molecular basis of agonism and antagonism in the estrogen receptor
39. Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist
40. Estrogen receptor (ER) modulators each induce distinct conformational changes in ERα and ERβ
41. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
42. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450 arom)
43. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
44. Pedriatic endocrinology update: An overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: Lessons from mutations in the genes for aromatase and the estrogen receptor
45. Estrogen and progesterone receptors in cytology: A comprehensive review
46. Molecular mechanisms of antiestrogen action in breast cancer
47. Estrogen receptors in breast cancer therapy
48. Expression of estrogen receptor-β in human breast tumors
49. Expression of estrogen receptor β1, β2, and β5 messenger RNAs in human breast tissue
50. Messenger ribonucleic acid in situ hybridization analysis of estrogen receptors α and β in human breast carcinoma
51. Estrogen receptors α and β in the rodent mammary gland
52. Estrogen receptor-β messenger RNA expression in human breast tumor biopsies: Relationship to steroid receptor status and regulation by progestins
53. Coexpression of estrogen receptor-α and -β: Poor prognostic factors in human breast cancer?
54. Perimenopausal and postmenopausal hormone replacement therapy. Part 1. An update of the literature on benefits and risks
55. Perimenopausal and postmenopausal hormone replacement therapy. Part 2. Hormonal regiments and complementary and alternative therapies
56. Expression of oestrogen receptor (ERβ) in multiple rat tissues visualised by immunohistochemistry
57. Differential expression of estrogen receptors α and β in adult rat accessory sex glands and lower urinary tract
58. Estrogen receptor-β: Implications for the prostate gland
59. Generation and reproductive phenotypes of mice lacking estrogen receptor β
60. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment
61. Hormonal prevention and treatment of osteoporosis - State of the art 1990
62. Estrogen replacement therapy and fractures in older women
63. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton
64. Estrogen binding receptor mRNA and biological response in osteoblast-like osteosarcoma cells
65. Evidence of estrogen receptors in normal human osteoblast-like cells
66. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells
67. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells
68. Expression of estrogen receptor β in rat bone
69. Differential expression of estrogen receptors α and β mRNA during differentiation of human osteoblast SV-HFO cells
70. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
71. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women
72. Postmenopausal hormone therapy and mortality
73. Estrogens and atherosclerosis
74. The protective effects of estrogen on the cardiovascular system
75. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells
76. Identification of authentic estrogen receptor in cultured endothelial cells: A potential mechanism for steroid hormone regulation of endothelial function
77. Human vascular smooth muscle cells contain functional estrogen receptor
78. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor β
79. Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury
80. Cardiac myocytes and fibroblasts contain functional estrogen receptors
81. Estrogen, progesterone, and vascular reactivity: Potential cellular mechanisms
82. Cardiovascular effects of estrogen: Implications of the discovery of the estrogen receptor subtype β
83. Acute activation of Maxi-k channels (hSlo) by estradiol binding to the β subunit
84. Non-genomic effects of estrogen and the vessel wall
85. Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen
86. Differential effects of 17β-estradiol on mitogen-activated protein kinase pathways in rat cardiomyocytes
87. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
88. Estrogen and the blood vessel wall
89. The vascular protective effects of estrogen
90. Expression of oestrogen receptor α and β in rat heart: Role of local oestrogen synthesis
91. Estrogen and postmenopausal estrogen/progestin therapy: Effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production
92. Oestrogen and progesterone inhibit the stimulated production of endothelin-1
93. Alternatives to the use of estrogen in postmenopausal women
94. Estrogen modulates AT1 receptor gene expression in vitro and in vivo
95. Estradiol protects against experimental cardiac transplant atherosclerosis
96. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury
97. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: Effects on migration and proliferation of vascular smooth muscle cells
98. Effects of gonadectomy and hormonal replacement on rat hearts
99. Effects of sex hormones on development of physiological and pathological cardiac hypertrophy in male and female rats
100. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice
101. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury
102. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice
103. Estrogen actions in the central nervous system
104. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: An in situ hybridization study
105. Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system
106. Responses in the brain of estrogen receptor α-disrupted mice
107. Expression and neuropeptidergic characterization of estrogen receptors (ERα and ERβ) throughout the rat brain: Anatomical evidence of distinct roles of each subtype
108. The estrogen receptor Β subtype: A novel mediator of estrogen action in neuroendocrine systems
109. Induction of progestin receptors by estradiol in the forebrain of estrogen receptor-β gene-disrupted mice
110. 125I-estrogen to estrogen receptor-β (ERβ) in the wild type and ERα-knockout (ERαKO) mouse brain
111. Biologically active estrogen receptor-β: Evidence from in vivo autoradiographic studies with estrogen receptor α-knockout mice
112. Estrogen receptor null mice: What have we learned and where will they lead us?
113. Cellular distribution and gene regulation of estrogen receptors α and β in the rat pituitary gland